Docetaxel suppressed cell proliferation through smad3/hif-1α-mediated glycolysis in prostate cancer cells

HIGHLIGHTS

• who: Junming Peng from the Hospital, Southern University of Science and TechnologyEngineering Center, Shenzhen, Guangdong, China have published the Article: Docetaxel suppressed cell proliferation through Smad3/HIF-1u03b1-mediated glycolysis in prostate cancer cells, in the Journal: (JOURNAL)
• what: The authors showed that docetaxel treatment led to a significant inhibition of cell proliferation in prostate cancer cells through PFKP-mediated glycolysis.
• how: Statistical differences among groups were determined by Student`s t-test one-way analysis of variance (ANOVA) was used to determine the significance for mRNA and intensity quantified. Consisted with this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.